Ligand’s Third Quarter Financial Results to be Reported October 30th

Go back to Ligand’s Third Quarter Financial Results to be Reported October 30th
LIGAND PHARMA (NASDAQ: LGND) Delayed: 285.60 -7.67 (2.62%)
Previous Close $293.27    52 Week High $139.79 
Open $294.99    52 Week Low $82.07 
Day High $294.99    P/E 664.19 
Day Low $285.24    EPS $0.43 
Volume 67,947